REACTIVATION OF HERPES EYE DISEASE
REACTIVATION OF HERPES EYE DISEASE
批准号:
2888527
负责人:
DAVID J. FINK
金额:
$16.78万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-08-01 至 2001-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Reactivation of herpes simplex virus (HSV) from latent
infection of neurons in the trigeminal ganglion is a major cause of
blindness. In order to define the molecular mechanisms of HSV
reactivation from latency, we propose to study the hypothesis that the
establishment of HSV latency reflects specific interactions between the
phenotype of the individual neuron and promoter elements in the HSV
genome, and the hypothesis that viral reactivation from latency results
from identifiable alterations in the neuronal gene expression.
Three specific aims are outlined. (1) To define the cellular phenotype
of neurons containing latent viral genomes, comparing neurons in which
the latent genomes express detectable LATs. The PI will use double-
label immunocytochemistry, in situ hybridization and in situ PCR on
serial 1 ym sections of ganglion to characterize cells into latent HSV
genomes by neurotransmitter phenotype, expression of high affinity growth
factor receptor, and the presence of transcriptional regulatory elements.
(2) To define the mechanisms responsible for reactivation of HSV from
latency on a cell specific basis. He will use similar methods after
reactivating the virus containing the earliest reactivating genomes.
(3) To empirically test the role of NGF and of the cellular immediate
early genes c-fos and c-jun in reactivation he will construct a virus
with the NGF gene driven by the ICP0 promoter to express NGF early in
the reactivation cascade in order to test whether NGF expression blocks
reactivation, and will construct a second recombinant lacking the cyclic
AMP response element (CRE) in ICP0 promoter in order to test whether
elevated expression of c-fos or c-jun by the cell activates ICP0
expression to cause entry of the latent genome into lytic cycle
activity.
The descriptive studies will define the phenotype of the cells harboring
latent genomes and the alterations in that phenotype which occur early
in the reactivation cascade. The viral constructs will empirically test
the potential role of specific elements. Together, these studies will
allow use to better understand the interaction between cellular and
viral elements that results in reactivation of latent genomes from the
trigeminal ganglion; an understanding that has important implications
for strategies to prevent viral reactivation from latency, and the
blindness which results from that reactivation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatable Gene Expression for Prevention of Neuropathy
-
批准号:8540668
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:DAVID J. FINK
-
依托单位:
Regulatable Gene Expression for Prevention of Neuropathy
-
批准号:8966656
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:DAVID J. FINK
-
依托单位:
Preclinical Development of an NT3-expressing HSV Vector
-
批准号:8100576
-
项目类别:
-
资助金额:$100.18万
-
财政年份:2011
-
负责人:DAVID J. FINK
-
依托单位:
Preclinical Development of an NT3-expressing HSV Vector
-
批准号:8549318
-
项目类别:
-
资助金额:$104.71万
-
财政年份:2011
-
负责人:DAVID J. FINK
-
依托单位:
Preclinical Development of an NT3-expressing HSV Vector
-
批准号:8326048
-
项目类别:
-
资助金额:$105.61万
-
财政年份:2011
-
负责人:DAVID J. FINK
-
依托单位:
HSV GAD for Painful Diabetic Neuropathy
-
批准号:7870164
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:DAVID J. FINK
-
依托单位:
HSV GAD for Painful Diabetic Neuropathy
-
批准号:8466768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:DAVID J. FINK
-
依托单位:
PAINFUL DIABETIC NEUROPATHY
-
批准号:7083037
-
项目类别:
-
资助金额:$36.16万
-
财政年份:2006
-
负责人:DAVID J. FINK
-
依托单位:
Gene Therapy for Pain
-
批准号:6665163
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2002
-
负责人:DAVID J. FINK
-
依托单位:
Gene Therapy for Pain
-
批准号:6546992
-
项目类别:
-
资助金额:$41.99万
-
财政年份:2002
-
负责人:DAVID J. FINK
-
依托单位:
Gene Therapy for Pain
-
批准号:6951234
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2002
-
负责人:DAVID J. FINK
-
依托单位:
Gene Therapy for Pain
-
批准号:6793538
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2002
-
负责人:DAVID J. FINK
-
依托单位:
CORE--VECTOR DESIGN AND PRODUCTION
-
批准号:6494881
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2001
-
负责人:DAVID J. FINK
-
依托单位:
CORE--VECTOR DESIGN AND PRODUCTION
-
批准号:6496812
-
项目类别:
-
资助金额:$17.32万
-
财政年份:2001
-
负责人:DAVID J. FINK
-
依托单位:
CORE--VECTOR DESIGN AND PRODUCTION
-
批准号:6356596
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2000
-
负责人:DAVID J. FINK
-
依托单位:
CORE--VECTOR DESIGN AND PRODUCTION
-
批准号:6358106
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:DAVID J. FINK
-
依托单位:
CORE--VECTOR DESIGN AND PRODUCTION
-
批准号:6296992
-
项目类别:
-
资助金额:$23.94万
-
财政年份:1999
-
负责人:DAVID J. FINK
-
依托单位:
GENE TRANSFER FOR PREVENTION OF DIABETIC NEUROPATHY
-
批准号:6394158
-
项目类别:
-
资助金额:$19.46万
-
财政年份:1999
-
负责人:DAVID J. FINK
-
依托单位:
Gene Transfer for Prevention of Diabetic Neuropathy
-
批准号:8049066
-
项目类别:
-
资助金额:$32.59万
-
财政年份:1999
-
负责人:DAVID J. FINK
-
依托单位:
Gene Transfer for Prevention of Diabetic Neuropathy
-
批准号:8258766
-
项目类别:
-
资助金额:$32.59万
-
财政年份:1999
-
负责人:DAVID J. FINK
-
依托单位:
海外基金